Abstract
Journal of Bone and Mineral Research, Journal of Bone and Mineral Research June 2006:21:965-976 (doi: 10.1359/jbmr.060308)

Full Text Printable PDF (5,018.432 KB)

RANKL-Induced Expression of Tetraspanin CD9 in Lipid Raft Membrane Microdomain Is Essential for Cell Fusion During Osteoclastogenesis

Masaru Ishii, 12   Kaori Iwai, 1   Masato Koike, 3   Shiro Ohshima, 1   Eriko Kudo-Tanaka, 2   Taeko Ishii, 4   Toru Mima, 2   Yoshinori Katada, 5   Kunio Miyatake, 6   Yasuo Uchiyama, 3   Yukihiko Saeki, 12  

1Department of Clinical Research, Osaka Minami Medical Center, Osaka, Japan;

2Division of Rheumatology, Osaka Minami Medical Center, Osaka, Japan;

3Department of Anatomy and Cell Biology, Osaka University Graduate School of Medicine, Osaka, Japan;

4Division of Allergy, Osaka Prefectural Medical Center for Allergy and Respiratory Diseases, Osaka, Japan;

5Division of Allergology, Osaka Minami Medical Center, Osaka, Japan;

6National Hospital Organization, Osaka Minami Medical Center, Osaka, Japan.

The authors state that they have no conflicts of interest.



We showed that CD9, a member of tetraspanin superfamily proteins, is expressed in a specific membrane microdomain, called “lipid raft,” and is crucial for cell fusion during osteoclastogenesis after activation of the RANK/RANKL system.

Introduction: Osteoclasts are bone-resorbing multinuclear polykaryons that are essential for bone remodeling and are formed through cell fusion of mononuclear macrophage/monocyte lineage precursors. Although osteoclastogenesis has been shown to be critically regulated by the RANK/RANKL system, the mechanism how precursor cells fuse with each other remains unclear. We examined the function of CD9, a member of tetraspanin superfamily, which has previously been shown to form macromolecular membrane microdomains and to regulate cell–cell fusion in various cell types.

Materials and Methods: We used RAW264.7, a macrophage/monocyte lineage cell line, which can differentiate into osteoclast-like polykaryons on the application of RANKL. Expression and distribution of CD9 was assessed by Western blotting, fluorescence-assorted cell sorting (FACS) and immunohistochemistry with light and electron microscopy. A specific neutralizing antibody and RNA interference were used to inhibit the function of CD9, and green fluorescent protein (GFP)-CD9 was exogenously expressed to enhance the effect of CD9. The distribution of CD9 in lipid microdomain was examined by biochemical (sucrose density gradient) isolation and imaging technique.

Results: CD9 is expressed on cell surfaces of RAW264.7, which is enhanced by RANKL. Targeted inhibition of CD9 decreases the number of osteoclast-like cells. On the other hand, overexpression of CD9 promotes spontaneous cell fusion even in the absence of RANKL. CD9 is localized in detergent-insoluble “lipid raft” microdomain in RANKL stimulation, and disruption of lipid rafts markedly reduces the formation of osteoclast-like polykaryons. Immunohistochemical studies of bone tissues revealed the expression of CD9 in osteoclasts in vivo.

Conclusions: These data suggest that function of tetraspanin CD9 and its expression in lipid rafts are crucial for cell fusion during osteoclastogenesis.

Cited by

Kaori Iwai, Masato Koike, Shiro Ohshima, Kunio Miyatake, Yasuo Uchiyama, Yukihiko Saeki and Masaru Ishii. (2007) RGS18 Acts as a Negative Regulator of Osteoclastogenesis by Modulating the Acid-Sensing OGR1/NFAT Signaling Pathway. Journal of Bone and Mineral Research 22:10, 1612-1620
Online publication date: 1-Oct-2007.
Abstract | Full Text | Printable PDF (3808 KB) 

 

Prev. Article | Next Article
View Printable PDF (5018 KB)
Add to favorites
Email to a friend
TOC Alert | Citation Alert What is RSS?

 
 
Quick Search
for 
Authors:
Masaru Ishii,
Kaori Iwai,
Masato Koike,
Shiro Ohshima,
Eriko Kudo-Tanaka,
Taeko Ishii,
Toru Mima,
Yoshinori Katada,
Kunio Miyatake,
Yasuo Uchiyama,
Yukihiko Saeki,
Keywords:
osteoclast
differentiation
cell fusion
tetraspanin
RANKL
lipid raft